Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

(MedPage Today) — Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall survival (OS), the phase…

Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117380

Author :

Publish date : 2025-09-09 19:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

‘Great Migration’ involves far fewer wildebeest than we had thought

CDC Autism Data Reviewed; Gabapentin Prescribing Concerns; Smoking and Parkinson’s

Related Posts

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Sesame Allergy Study Compares Oral Food Challenge Methods

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Sesame Allergy Study Compares Oral Food Challenge Methods

What’s in the New Settlement Against OxyContin-Maker Purdue and the Sackler Family

Racial Disparities in C-Sections Persist Despite Overall Decrease

Categories

Archives